154
Aura Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
197
FY23:
232
FY24:
161
FY25:
150
(positive)
Change from FY21 to FY25
millions USD
FY21:
6.33
FY22:
27.2
FY23:
23.3
FY24:
21.9
FY25:
19.7
Total assets
Change from FY21 to FY25
millions USD
FY21:
160
FY22:
224
FY23:
255
FY24:
183
FY25:
169
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
7.36
FY22:
10.5
FY23:
12.4
FY24:
14.9
FY25:
18.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.36
FY22:
17.9
FY23:
16.9
FY24:
15.6
FY25:
14.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
152
FY22:
196
FY23:
226
FY24:
152
FY25:
137
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
160
FY22:
224
FY23:
255
FY24:
183
FY25:
169
All amounts in millions USD